Highlights & Updates
The following list of topics is a sampling of posts made to Pharma Marketing Blog in the past month or so. Some additional information...
Precision Buzz Marketing
Pharma companies have long ago mastered the art and science of "Precision Marketing" to physicians. No where has this prowess been demonstrated more conclusively...
WLF: A No-Risk Ad is a Good Ad
According to a recent story in BrandWeek, "The Washington Legal Foundation, a conservative think tank, filed a petition with the Food and Drug Administration...
Brand Extinction Looms
According to a Forbes article, "By 2011, a quarter of current drug sales in the U.S. will be eaten away by less expensive generic...
McKinnell’s New Gig: Male Model
Pfizer's CEO Hank McKinnell -- soon to retire -- has lost no time finding another gig: that of male model for pharmaceutical vendor ads....
Sicko si, Pharmaco no!?
Last February I wrote about Michael Moore's new film "Sicko" and suggested that it will be about Moore than the pharmaceutical industry (see "Michael...
Patient Advocacy Marketing: US vs Them
It's hard to do pharmaceutical marketing in the UK and the rest of Europe, which probably explains why my Pharma Marketing News subscriber list...
Vioxx Scorecard: 5-3-14192
As reported on CNNMoney.com, Merck won the most recent case in a Los Angeles state court on August 2, 2006, when a jury found...
Kindler Fox in Pfizer Henhouse (aka Bunker)
In this month's Pharmaceutical Executive Magazine feature article, "The Inside Man," Mr. Jeffrey Kindler -- recently named new CEO at Pfizer -- is said...
Anonymous Online Marketing
I have written about "Stealth Marketing" in which marketers attempt to embed their messages in "buzz" channels such as blogs (see "Buzz 'n Blogs...
